The Matrix Protocol: DMT, the Brain, and Consciousness Transfer Immersive Technology

@UAMNTV In this workshop, we explore the potential for transferring consciousness into alternate realities using the Induction-Immersion-Integration (III) Protocol. Delve into how the brain generates subjective worlds and its connection to external reality. Discover how DMT triggers brain channel switches to access hidden realities. Join the discussion on implementing the III Protocol in humans. A fascinating journey into the future of consciousness with a distinguished computational neurobiologist, pharmacologist, chemist, and prolific writer Dr. Andrew Gallimore.

Presented by Dr. Andrew Gallimore

Dr. Andrew Gallimore is a distinguished computational neurobiologist, pharmacologist, chemist, and prolific writer with a long-standing fascination for deciphering the neural mechanisms underpinning the profound effects of psychedelic substances. Renowned for his extensive body of work, Dr. Gallimore has authored numerous research papers and articles dedicated to elucidating the enigmatic properties of N,N-dimethyltryptamine (DMT) and its profound impact on the human brain and consciousness.

Recently, he embarked on a groundbreaking collaboration with Dr. Rick Strassman, a pioneering figure in the realm of DMT research and author of 'DMT: The Spirit Molecule.' Together, they developed a groundbreaking pharmacokinetic model for DMT, forming the cornerstone of a target-controlled intravenous infusion protocol specially designed for extended journeys into the expansive realms of DMT consciousness.

Dr. Gallimore's current research endeavors center around DMT's unique potential as a gateway to extradimensional realities and the intriguing intersection between this phenomenon and the intricate field of neuroscience. Currently, he resides and conducts his innovative research in Japan.

Twitter: @alieninsect
Website: alieninsect.net
YouTube channel @aliensect

This channel is managed by Zohar Entertainment Group UK, Zohar Entertainment Group International Inc, USA and AdRev, USA.